Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2024
Grifols’ positive fibrinogen phase 3 trial results published in The Lancet’s eClinicalMedicine
Grifols successfully completes Biotest delisting
Access all the information about Grifols’ 2025 Annual General Meeting.
Our media relations team can be reached at:
(+34) 93 571 00 02
media@grifols.com.
Restricted to media inquiries only.
For general questions and requests, please contact corporatecomms@grifols.com.
Follow us on social media.
Seeking early biological signs of disease.
Newsroom
Access our latest press releases.
Media Center
Downloadable resources for media professionals.